
Eli Lilly Begins Phase III Study of RA Drug to Treat COVID-19
Eli Lilly will assess its JAK1/JAK2 inhibitor Olumiant (baricitinib) as a potential treatment for COVID-19…
Eli Lilly will assess its JAK1/JAK2 inhibitor Olumiant (baricitinib) as a potential treatment for COVID-19…
May 7, 2020 Israel’s Defence Minister Naftali Bennett said scientists at the Israel Institute of…
May 7, 2020 There’s been a lot of excitement about the potential of antibody-based blood…
May 06, 2020 Italy has announced that it has successfully developed a vaccine to contain…
May 6, 2020 More than 7,000 papers on the pandemic—covering everything from virology to epidemiology—have…
May 1, 2020 Of the 12 antibody tests that were studied by the COVID-19 Testing Project,…
Four Indian scientists from ICMR-NIV deposited first genome of coronavirus from India to NCBI Genbank.…
Shashi Meena, Shivani Nagar & Archana watts Division of Plant Physiology, ICAR-Indian Agricultural Research Institute,…
The Federal Government of Nigeria has approved commercialization of a biotech cowpea variety resistant to…
Jan 2020 The Chinese scientist who created the world’s first gene-edited children has been sentenced…